Jim Nelson says savvy investors can make huge profits in the first 100 days of the Obama presidency. Three sectors facing a makeover under the new administration are biotechnology, renewable energy and defense. Jim says new legislation and funding could mean big gains for these three companies…

Laura Cadden says Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is on the verge of a big breakthrough with a drug to treat sleep disorders. She says investors that buy the stock at or below 75 cents will be in line for double-digit gains.

Laura Cadden says Aastrom Biosciences, Inc. (NASDAQ:ASTM) is one of the hottest biotech stocks priced under $5. The company hopes to use its proprietary Tissue Repair Cell (TRC) technology to revolutionise treatment for heart disease. And it is making good progress through the trial phases. Laura says Aastrom is poised to make 20% gains in six months

New breakthroughs in adult stem cell technology offer staggering implications for medical science, says Patrick Cox. And a massive opportunity for investors. As Big Pharma move in, Patrick says biotech companies involved in stem cell research and RNA technology could become the “investment of a lifetime.”

One of the biggest impacts of the new administration could be in stem cell research, according to Laura Cadden. Support for the use of embryonic stem cells would open a whole world of opportunity for specialist biotech firms. Laura picks 5 small-cap biotech stocks that would make huge gains on new stem cell legislation.

Martin Hutchinson analyses what a Democrat landslide means for investors. He says nuclear and clean energy stocks, auto manufacturers, generic drug producers and muni bonds are a “buy”. But fossil fuel companies and financial institutions should be avoided.

Laura Cadden has found a small cap biotech company with huge growth potential. OpenCell BioMed Inc. (OTC:OCBM) is hoping to revolutionize dental surgery using titanium to help fix implants. Laura says investors willing to take on a risky venture could win big with ‘early-mover’ profits.

The stock market is due a bounce after the election, regardless of who wins. But after that, the voter’s choice will have a big impact on industry winners and losers. Rick Pendergraft says biotech and alternative energy stocks should get a lift under Obama, while defense and oil will benefit from a McCain victory.

How will the stock markets respond to a new US president? Martin Delholm says the impact will be less than some people expect. But some sectors will benefit from a regime change. With Obama the clear favourite to win, Martin recommends three clean energy stocks likely to gain from new subsidies.

Oil Bounces Back; Hungary Gets $25 Billion in Aid; P&G Boosted by Emerging Markets; Qwest Cuts Workforce; Airline Merger Cleared for Takeoff; Domestic Airfares Soar to Record High; Consumer Crunch Hits Comcast; Biotech Firm Plunges